On April 27, 2022 ISA reported that its representatives will be participating and presenting at the following business conferences in May 2022 (Press release, ISA Pharmaceuticals, APR 27, 2022, View Source [SID1234613011]). If you would like to meet with our team at any of these events, please contact us through the conference partnering systems or via [email protected].
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
LSX World Leaders Congress
Date: 10-11 May 2022, London, UK
Panel Presentation by: Anton Mat, Director Business Development, ISA Pharmaceuticals
Title: Key Multi-Stakeholder Considerations In Early-Stage Commercial Deal-Making
Date & Time: Tuesday, 10 May 2022, 14.30pm BST
Bio€quity Europe
Date: 16-18 May 2022, Milan, Italy
Presentation by: Gerben Moolhuizen, Chief Executive Officer, ISA Pharmaceuticals
Date & Time: Virtual, pre-recorded presentation available any time via the partnering system
UBS Global Healthcare Conference
Date: 23-25 May 2022, New York, US
Presentation by: Gerben Moolhuizen, Chief Executive Officer, ISA Pharmaceuticals
Title: ISA Pharmaceuticals Company Presentation
Date & Time: Monday, 23 May 2022, 07.45am ET